申请人:Jansen M. Johanna
公开号:US20060079564A1
公开(公告)日:2006-04-13
Organic compounds having the structure I are provided where the variables have the values described herein.
A method of inhibiting c-ABL in a patient includes administering an effective amount of a compound of structure I, a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer to the patient.
提供具有结构I的有机化合物,其中变量具有所述值。一种抑制患者中c-ABL的方法包括向患者投与结构I的化合物,化合物的互变异构体,化合物的药学上可接受的盐或互变异构体的药学上可接受的盐的有效量。